Results 21 to 30 of about 1,661 (172)

Psychometric Hepatic Encephalopathy Score in the Diagnosis of Minimal Hepatic Encephalopathy in Cirrhosis of Liver: A Cross-sectional Study

open access: yesJournal of Clinical and Diagnostic Research
Introduction: Minimal Hepatic Encephalopathy (MHE) is a subclinical condition in patients with liver cirrhosis, often preceding Overt Hepatic Encephalopathy (OHE).
Mounika Maragari   +3 more
doaj   +2 more sources

Evaluation of IL‐6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis [PDF]

open access: yesHepatology Communications, 2022
Diagnosis of minimal hepatic encephalopathy (MHE) requires psychometric testing, which is time‐consuming and often neglected in clinical practice. Elevated Interleukin‐6 (IL‐6) serum levels have been linked to MHE.
Simon Johannes Gairing   +10 more
doaj   +2 more sources

Relationship between Sarcopenia and minimal hepatic encephalopathy in patients with cirrhosis: a prospective observational study

open access: yesBMC Gastroenterology
Background Sarcopenia, characterized by loss of muscle mass and function, has gained importance in the evaluation of cirrhotic patients. Evidence suggests its role in adverse clinical outcomes, including minimal hepatic encephalopathy (MHE).
Wasit Wongtrakul   +2 more
doaj   +2 more sources

Detection of Minimal Hepatic Encephalopathy: Validation of Indonesian Norms for Psychometric Hepatic Encephalopathy Score

open access: yesThe Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy
Saut Horas Hatoguan Nababan
doaj   +2 more sources

Stroop test, Quickstroop, and the 1-min animal naming test for minimal hepatic encephalopathy diagnosis: A multicenter study in Mexico

open access: yesAnnals of Hepatology
Introduction and Objectives: Although the Psychometric Hepatic Encephalopathy Score (PHES) remains the gold standard in diagnosing minimal hepatic encephalopathy (MHE), its complexity limits its application in clinical practice.
Juan F. Ortiz-Treviño   +3 more
doaj   +2 more sources

S100 Beta as a Marker of Section Hepatic Encephalopathy: A Case-control Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2023
Introduction: Hepatic Encephalopathy (HE) is a term used to describe a reversible syndrome of impaired brain function involving a complex spectrum of non specific neurological and psychiatric manifestations occurring in patients of severe acute or ...
Manish Chandey   +3 more
doaj   +1 more source

Assentment of the influence of liver cirrhosis and minimal hepatic encephalopathy on quality of life

open access: yesClinical and Biomedical Research, 2014
Introduction: Minimal hepatic encephalopathy (MHE) has been associated with changes in the ability to drive, with the onset of the explicit form of hepatic encephalopathy and with a worse prognosis.
Diana Santos   +5 more
doaj   +3 more sources

Plasma Ammonia Levels Predict Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement. [PDF]

open access: yesUnited European Gastroenterol J
ABSTRACT Background Placement of a transjugular intrahepatic portosystemic shunt (TIPS) is an effective treatment for portal hypertension. Overt hepatic encephalopathy (oHE) is a complication after TIPS associated with increased morbidity. Elevated ratio of plasma ammonia (AMM) levels compared to the local upper limit of normal (ULN) has been ...
Sandmann L   +10 more
europepmc   +2 more sources

Fecal Calprotectin in Patients with Hepatic Encephalopathy [PDF]

open access: yesAfro-Egyptian Journal of Infectious and Endemic Diseases, 2018
Background and study aim: Cal-protectin is a cytoplasmatic protein of neutrophilic granulocytes and it is an established marker for the assessment of localized intestinal inflammation .Bacterial translocation is known to play an important role in the ...
Waleed Al Azab   +4 more
doaj   +1 more source

Neurofilament Light Chains in Serum Predict Post-Transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy. [PDF]

open access: yesMedComm (2020)
Hepatic encephalopathy (HE) after transjugular intrahepatic portosystemic shunt (TIPS) insertion constitutes a frequent and severe complication, however, biomarkers are currently scarce. The results of this study indicate that neurofilament light chains (NfL) in serum, but not glial fibrillary acidic protein (GFAP), is a useful biomarker identifying ...
Labenz C   +16 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy